Are unreproducible results in cancer research harming patients?

The ability to reproduce results of published experiments helps prove affectability in future implementation. A major project in measuring the reliability of cancer research has found a lack of reproducibility to be damaging to the advancement of cancer treatments.

When cancer research is incapable of being reproduced by other researcher teams, the research is often left in the heap of unfinished projects. This heap is growing and growing while methods of cancer treatments remain stuck.

"Reproducibility is a central feature of how science is supposed to be," says Brian Nosek, a psychology professor at the University of Virginia.

An NPR article by Richard Harris explores reproducing cancer findings and what it means for the advancement of treatments. See the item below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”